Addition of 2 cycles of EP (Etoposide Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years.


İÇLİ F., AKBULUT H., DİNÇOL D., ONUR H., DEMİRKAZIK A., ÇAM R., ...More

Journal of Clinical Oncology, ASCO Annual Meeting Proceedings, 15 July 2005

  • Publication Type: Conference Paper / Summary Text